Wilson Araújo Silva Selected Research

Recessive Intermediate A Charcot-Marie-Tooth Disease

1/2021

GDAP1 mutations are frequent among Brazilian patients with autosomal recessive axonal Charcot-Marie-Tooth disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wilson Araújo Silva Research Topics

Disease

13	Neoplasms (Cancer) 01/2022 - 01/2009
5	Carcinogenesis 01/2021 - 01/2009
3	Melanoma (Melanoma, Malignant) 01/2022 - 12/2017
3	Infections 11/2019 - 01/2003
2	Carcinoma (Carcinomatosis) 12/2017 - 08/2014
2	Pituitary Neoplasms (Pituitary Adenoma) 12/2012 - 01/2009
1	Hypoxia (Hypoxemia) 02/2024
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 09/2021
1	Adenoma (Adenomas) 03/2021
1	Adenocarcinoma 03/2021
1	Type 4A Charcot-Marie-Tooth disease 01/2021
1	Type 2K Charcot-Marie-Tooth disease 01/2021
1	Recessive Intermediate A Charcot-Marie-Tooth Disease 01/2021
1	Metabolic Diseases (Metabolic Disease) 11/2020
1	Maple Syrup Urine Disease 11/2020
1	Amenorrhea 03/2020
1	Hypertension (High Blood Pressure) 03/2020
1	Hypogonadism (Hypergonadotropic Hypogonadism) 03/2020
1	Endometrial Neoplasms (Endometrial Cancer) 01/2020
1	Tuberculosis (Tuberculoses) 07/2019
1	Fibrosis (Cirrhosis) 02/2019
1	Inflammation (Inflammations) 01/2018
1	Thyroid Diseases (Thyroid Disease) 12/2017
1	Thyroid Neoplasms (Thyroid Cancer) 12/2017
1	Testicular Neoplasms (Testicular Cancer) 12/2017
1	Medullary Carcinoma 12/2017
1	Goiter 12/2017
1	Choriocarcinoma 01/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2014
1	Disease Resistance 03/2014
1	Breast Neoplasms (Breast Cancer) 12/2013
1	Growth Hormone-Secreting Pituitary Adenoma 12/2012
1	Pituitary ACTH Hypersecretion 01/2009
1	Hepatitis B 01/2003
1	Liver Diseases (Liver Disease) 01/2003

Drug/Important Bio-Agent (IBA)

4	Long Noncoding RNAIBA 01/2022 - 12/2013
4	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2003
3	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 01/2017
3	Messenger RNA (mRNA)IBA 08/2014 - 01/2009
2	Biomarkers (Surrogate Marker)IBA 02/2024 - 12/2017
2	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2020 - 01/2009
2	MicroRNAs (MicroRNA)IBA 05/2018 - 01/2009
2	Biocompatible Materials (Biomaterials)IBA 01/2017 - 06/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2024
1	VemurafenibIBA 01/2022
1	IronIBA 09/2021
1	Chelating AgentsIBA 09/2021
1	Genetic Markers (Genetic Marker)IBA 03/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	GDAP proteinIBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 11/2020
1	AcidsIBA 11/2020
1	Epithelial Cell Adhesion MoleculeIBA 10/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2020
1	CorticosteroneIBA 03/2020
1	Exonucleases (3' 5' Exonuclease)IBA 01/2020
1	Terbinafine (Lamisil)FDA LinkGeneric 11/2019
1	Rifampin (Rifampicin)FDA LinkGeneric 07/2019
1	Plasminogen Activator Inhibitor 1IBA 02/2019
1	Simvastatin (Zocor)FDA LinkGeneric 02/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2019
1	Zinc Finger E-box-Binding Homeobox 1IBA 01/2019
1	Antisense RNA (Anti-Sense RNA)IBA 01/2019
1	Interleukin-12 (IL 12)IBA 01/2018
1	NucleotidesIBA 01/2018
1	AntigensIBA 12/2017
1	Tumor Biomarkers (Tumor Markers)IBA 01/2016
1	LatexIBA 03/2014
1	Small Interfering RNA (siRNA)IBA 12/2013
1	Ribosomal Proteins (Ribosomal Protein)IBA 12/2012

Therapy/Procedure

1	Therapeutics 12/2017
1	Aftercare (After-Treatment) 01/2009
1	Renal Dialysis (Hemodialysis) 01/2003